1. EachPod

How to Successfully Market to Pharmaceutical and Biotechnology Industries

Author
World Innovators, Inc.
Published
Tue 04 May 2021
Episode Link
https://the-world-innovators-podcast.simplecast.com/episodes/how-to-successfully-market-to-pharmaceutical-and-biotechnology-industries-z5ipY5NG

Last week I was doing research in the pharmaceutical and biotechnology space and came across these two statistics that blew me out of the water: 

1)   Global Market Insights reports that the global biotechnology market size is projected to surpass USD $775 billion by 2025.

2)   Global Newswire reports that the global pharmaceutical manufacturing market is to grow from USD $357 billion to $1173 billion by 2030.

This expected growth will increase the demand for various biotechnology & pharmaceutical manufacturing products. Companies working in this Bio/Pharm space have to find quality Direct Marketing options that can reach their target audience by Title, Industry, Interest, Technologies Used, etc…

This is why I asked my guest Amy Miller to come back on The World Innovators Podcast to specifically talk about the Bio/Pharma area. Here are some of the topics we discussed:

  • The importance of reaching a specific audience that would be interested in the product or service being promoted.  For example - reaching people involved in Gene Regulation Therapy, Clinical Trials, Assay, etc.…
  • Direct marketing is a great way to get your message in front of the right people interested in buying.
  • Set up your marketing strategy so that you concentrate on building partnerships/relationships and the sales will come.
  • How to protect your company from being blacklisted and your company's online promotions from being shut down.

🎧 Visit www.worldinnovators.com to learn how we can help you build marketing that connects.

👉 Have questions or want Donna to present this topic to your team? Reach out at [email protected].

🔔 Don’t forget to subscribe to the B2B Marketing Excellence & AI Podcast so you never miss an episode!

Share to: